These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 14501285)
21. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Nahabedian MY; Tufaro AP; Manson PN Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009 [TBL] [Abstract][Full Text] [Related]
22. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622 [TBL] [Abstract][Full Text] [Related]
23. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases. Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828 [TBL] [Abstract][Full Text] [Related]
24. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes? Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963 [TBL] [Abstract][Full Text] [Related]
25. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514 [TBL] [Abstract][Full Text] [Related]
26. Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence. Tatlidil C; Parkhill WS; Giacomantonio CA; Greer WL; Morris SF; Walsh NM Mod Pathol; 2007 Apr; 20(4):427-34. PubMed ID: 17334354 [TBL] [Abstract][Full Text] [Related]
37. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306 [TBL] [Abstract][Full Text] [Related]
38. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
39. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721 [TBL] [Abstract][Full Text] [Related]